BioHealth News Archive
Novavax Expands Executive Leadership and Announces Key Promotions | Novavax Inc. – IR Site
GAITHERSBURG, Md., June 29, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced…
Read More
MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator | Business Wire
LOS ANGELES--(BUSINESS WIRE)--MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, today announced the 50 companies selected to participate in the organization’s…
Read More
Charles Andres and Christian Barrow join BioTalk to discuss investing, growth and the BioHealth Capital Region during COVID-19
Charles Andres, Ph.D., RAC, Associate at Wilson Sonsini Goodrich & Rosati, and Christian Barrow, Executive Director, Life Sciences Banking at JP Morgan, join Rich…
Read More
The BioHealth Capital Region Featured at Digital RESI LSN Global Conference
The Life Science Network's Digital Redefining Early State Investments (RESI) took place online June 8-10, 2020, and featured some of the most knowledgeable voices…
Read More
CrazyCap helps Martine Rothblatt Cheer On Her Team Through Crisis! – PharmiWeb.com
MIAMI, June 22, 2020 /PRNewswire/ -- Esteemed lawyer, author, and entrepreneur, Martine Rothblatt, Ph.D., found a thoughtful and practical way to thank her employees at…
Read More
Preclinical Data for PRGN-3005 UltraCAR-T® Demonstrate Superior Expansion and Persistence of UltraCAR-T Compared to Traditional CAR-T | BioSpace
GERMANTOWN, Md., June 22, 2020 /PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the…
Read More
Altimmune Announces IND Clearance for a Phase 2 Trial of HepTcell™ Immunotherapeutic for the Treatment of Chronic Hepatitis B | BioSpace
GAITHERSBURG, Md., June 22, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug…
Read More
Emergent to add gene therapy capacity – Bioprocess InsiderBioProcess International
Emergent Biosolutions has set out to capture a share of the expanding viral vector and gene therapy sector. The US countermeasures developer said it…
Read MoreBIA | EPIDAREX CAPITAL CLOSES NEW £102 MILLION UK VENTURE FUND TO BUILD SUCCESSFUL LIFE SCIENCE COMPANIES
Edinburgh, UK, 22 June 2020 - Epidarex Capital (“Epidarex”), a transatlantic life science venture firm, announces that it has closed Epidarex Capital III UK…
Read More
AstraZeneca agrees to make Covid-19 vaccine for Europe | BreakingNews.ie
Pharmaceutical giant AstraZeneca has struck a deal with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental Covid-19 vaccine,…
Read More
Children’s National Hospital ranked a top 10 children’s hospital and No. 1 in newborn care nationally by U.S. News for fourth year in a row
WASHINGTON, June 16, 2020 /PRNewswire/ -- Children's National Hospital in Washington, D.C., was ranked No. 7 nationally in the U.S. News & World Report 2020-21…
Read More
GMU selects three finalists for $250M Institute for Digital InnovAtion | Virginia Business
George Mason University on Monday announced three development and property management firms as finalists to build and operate its proposed $250 million Institute for…
Read More
AstraZeneca taps Catalent for COVID-19 vaccine finishing, packaging at Italian plant | FiercePharma
British drugmaker AstraZeneca is shooting for the moon with its plan to produce 2 billion doses per year of a potential COVID-19 vaccine. To…
Read More
University of Maryland Medical System awarded $18.7 million federal grant to fight coronavirus – Baltimore Sun
The University of Maryland Medical System will receive more than $18.7 million in funding from the Federal Emergency Management Agency (FEMA) in the ongoing…
Read More
GSK gets FDA approval for HIV drug for children – MarketWatch
Shares of GlaxoSmithKline GSK, +0.36% were down 0.05% in premarket trading on Monday after the Food and Drug Administration late on Friday approved its…
Read More